# Facial Feminization Surgery and Quality of Life in Transgender Women: Protocol for a Cohort Study

## TL;DR

This study aims to develop and validate a Spanish-language quality-of-life questionnaire for transgender women in Chile who undergo facial feminization surgery and assess the surgery's impact on their well-being and facial features.

## Contribution

The study introduces the first validated Spanish-language quality-of-life instrument for transgender women undergoing facial feminization surgery in Latin America.

## Key findings

- The study will evaluate the psychosocial and physical outcomes of facial feminization surgery using patient-centered and objective measures.
- It will provide multidimensional evidence of surgical outcomes to support inclusive care and policy development for transgender health in Chile.
- Phase 1 has already exceeded the required sample size, with data analysis ongoing.

## Abstract

Transgender women face significant health inequities. Facial feminization surgery is an intervention that aligns craniofacial structures with female anatomical norms and gender identity. Although international studies suggest that facial feminization surgery improves psychosocial outcomes, most studies have focused on aesthetic results or relied on generic quality-of-life instruments that have not been validated for this population. In Chile, no study has evaluated the multidimensional impact of facial feminization surgery using patient-centered measures combined with objective cephalometric and photometric analyses. Moreover, no validated Spanish-language quality-of-life instrument exists for transgender women undergoing this surgery.

This study aims to (1) develop and validate a culturally appropriate quality-of-life questionnaire for transgender women undergoing facial feminization surgery in Chile, and (2) evaluate postoperative changes in quality of life, perception of facial femininity, and cephalometric and photometric parameters.

The study will include 2 methodological phases: a cross-sectional validation study and a longitudinal cohort study. Phase 1 involves questionnaire development and validation, following the COSMIN (Consensus-Based Standards for the Selection of Health Measurement Instruments) guidelines, with a systematic literature review conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, expert panel content validation, pilot testing, and psychometric evaluation in a cohort of ≥200 transgender women. Phase 2 is a longitudinal cohort study conducted at San Juan de Dios Hospital in Santiago, Chile, following the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines. Thirty transgender women scheduled for facial feminization surgery will be assessed at baseline and 12 months postoperatively. Outcomes include quality of life, self-perceived and third-party–rated femininity, and cephalometric and photometric changes (using cone beam computed tomography). Data analyses include exploratory and confirmatory factor analyses, Cronbach α, paired 1-tailed t tests or Wilcoxon signed-rank tests, chi-square or Fisher tests, and linear regression models.

This study was funded in October 2023. Phase 1 (January 2024 to January 2025) included 216 participants, exceeding the minimum sample size requirement. Data analysis is ongoing, and results will be reported separately. Phase 2 is in progress, with preoperative cone beam computed tomography scans and photographs being collected. The validated preoperative questionnaire will be administered in late 2025, with surgeries scheduled throughout 2026. Data collection is expected to conclude in 2027.

This protocol addresses a critical evidence gap in Latin America by integrating psychometric validation and longitudinal evaluation of facial feminization surgery outcomes among transgender women in Chile. The project is expected to develop the first validated Spanish-language quality-of-life instrument specific to facial feminization surgery, alongside multidimensional evidence of surgical outcomes. The findings will inform clinical decision-making, contribute to inclusive patient-centered care, and support the development of evidence-based policies for transgender health in the region.

DERR1-10.2196/75065